To develop a solution for the exploration of rare diseases on the whole genome of a patient, we need to have benchmark data for testing the efficacy of our solution. As rare diseases are complex – finding the genetic needle in the haystack – having a solution that will explore the entire human genome, both the coding and the non-coding component will bring us closer to solving this complex puzzle.
